Market Overview

Earnings Scheduled For July 2

Related AYI
Oppenheimer's Top Stock Picks For December
Lightning Round: Jim Cramer Weighs In On Lumber Liquidators, ADP And More
Acuity Brands drops 6.5% on Baird Lighting Survey (Seeking Alpha)
Related AGN
Wall Street's M&A Chatter From December 12: Fox-Disney, Repros Therapeutics-Allergan, Agrium-Macrofertil
Lightning Round: Jim Cramer Shares His Thoughts On Allergan, ETP, Cisco And More
Prospects dim for European approval of Repros' enclomiphene for secondary hypogonadism; shares down 10% after hours (Seeking Alpha)

Acuity Brands (NYSE: AYI) is estimated to report its Q3 earnings at $0.78 per share on revenue of $491.70 million.

Allergan (NYSE: AGN) is expected to post its Q2 EPS at $1.06 on revenue of $1.51 billion.

Posted-In: Earnings ScheduledEarnings News Pre-Market Outlook Markets


Related Articles (AGN + AYI)

View Comments and Join the Discussion!

Partner Center